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Abstract
Organophosphate (OP) compounds are widely used as pesticides and herbicides and exposure to these compounds has been 
associated with both chronic and acute forms of neurological dysfunction including cognitive impairment, neurophysiological 
problems and cerebral ataxia with evidence of mitochondrial impairment being associated with this toxicity. In view of the 
potential mitochondrial impairment, the present study aimed to investigate the effect of exposure to commonly used OPs, 
dichlorvos, methyl-parathion (parathion) and chloropyrifos (CPF) on the cellular level of the mitochondrial electron transport 
chain (ETC) electron carrier, coenzyme  Q10  (CoQ10) in human neuroblastoma SH-SY5Y cells. The effect of a perturbation 
in  CoQ10 status was also evaluated on mitochondrial function and cell viability. A significant decreased (P < 0.0001) in 
neuronal cell viability was observed following treatment with all three OPs (100 µM), with dichlorvos appearing to be the 
most toxic to cells and causing an 80% loss of viability. OP treatment also resulted in a significant diminution in cellular 
 CoQ10 status, with levels of this isoprenoid being decreased by 72% (P < 0.0001), 62% (P < 0.0005) and 43% (P < 0.005) of 
control levels following treatment with dichlorvos, parathion and CPF (50 µM), respectively. OP exposure was also found to 
affect the activities of the mitochondrial enzymes, citrate synthase (CS) and mitochondrial electron transport chain (ETC) 
complex II+III. Dichlorvos and CPF (50 µM) treatment significantly decreased CS activity by 38% (P < 0.0001) and 35% 
(P < 0.0005), respectively compared to control levels in addition to causing a 54% and 57% (P < 0.0001) reduction in com-
plex II+III activity, respectively. Interestingly, although  CoQ10 supplementation (5 μM) was able to restore cellular  CoQ10 
status and CS activity to control levels following OP treatment, complex II+III activity was only restored to control levels 
in neuronal cells exposed to dichlorvos (50 µM). However, post supplementation with  CoQ10, complex II+III activity sig-
nificantly increased by 33% (P < 0.0005), 25% (P < 0.005) and 35% (P < 0.0001) in dichlorvos, parathion and CPF (100 µM) 
treated cells respectively compared to non-CoQ10 supplemented cells. In conclusion, the results of this study have indicated 
evidence of neuronal cell  CoQ10 deficiency with associated mitochondrial dysfunction following OP exposure. Although 
 CoQ10 supplementation was able to ameliorate OP induced deficiencies in CS activity, ETC complex II+III activity appeared 
partially refractory to this treatment. Accordingly, these results indicate the therapeutic potential of  CoQ10 supplementation 
in the treatment of OP poisoning. However, higher doses may be required to engender therapeutic efficacy.
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Introduction
Organophosphate (OP) compounds are used as pesticides 
and herbicides [1]. They are generally derived from esters 
of phosphoric acid [2]. These toxic synthetic compounds 
including dichlorvos, methyl-parathion (parathion) and 
chloropyrifos (CPF) can cause a neurological syndrome 
called OP poisoning, which can display itself in both acute 
and chronic forms [3]. OP poisoning appears to be less 
prevalent in the UK, compared to developing countries [4]. 
However, it is becoming increasingly apparent that sheep 
farmers exposed to OP-based sheep dip are at a high risk 
of developing OP poisoning [5, 6]. As well as agricultural 
farmers, air craft cabin crew [7] and military personnel 
(Gulf war syndrome) are susceptible [8]. In farmers, OP 
poisoning as a result of exposure to OP based-sheep dip, 
via both inhalation and direct skin contact, can result in 
chronic health defects including neurological problems, 
muscle pain and fatigue [9]. Interestingly similar clinical 
presentations have been observed in Gulf war syndrome, 
an illness which developed not long after deployment of 
war veterans to the 1991 Gulf war [10, 11]. However, 
although the origin of Gulf war syndrome remains to be 
uncertain, it has been attributed to exposure of pesticides 
[12].
The mechanism of action of these OPs involves the 
inhibition of the nerve transmission enzyme acetylcho-
linesterase (AChE), which is required for the degradation 
of acetylcholine [13]. Persistence of acetylcholine at the 
cholinergic synapses due to AChE inhibition results in 
insect death due to hyper-excitation [14], and indeed, this 
also remains the most common adverse side effect of OP 
exposure in humans [15, 16]. In addition to this, OP poi-
soning has been associated with mitochondria dysfunction 
[17]. Clinical presentations have also been observed in 
OP patients which indicate evidence of mitochondrial dys-
function including fatigue [18], peripheral neuropathy [19] 
and cerebral ataxia [20]. Interestingly, cerebral ataxia is 
also a prominent feature of severe Coenzyme  Q10  (CoQ10) 
deficiency [21, 22].
Support for the potential mitochondrial toxicity of OPs 
has been provided by identified mitochondrial dysfunc-
tion as a result of exposure to OPs. This includes reduc-
tion in the activity of mitochondrial electron transport 
chain (ETC) enzymes, complex I (NADH: ubiquinone 
reductase), complex II (succinate dehydrogenase: ubiqui-
none reductase) and complex IV (cytochrome c oxidase) 
enzymes in rat studies [23], reduction in mitochondrial 
complex I-III (NADH: cytochrome c reductase) activ-
ity, which can in turn affect the production of ATP [24]. 
Mitochondrial swelling and elevated cytochrome c levels 
have also been observed in rabbit livers treated with the 
OP, chloropyrifos [17]. Interestingly, these alterations also 
appeared to correlate with elevated oxidative stress levels 
in rabbit’s liver. Furthermore, evidence of oxidative stress 
as a result of OP exposure has also been observed in vivo 
as elevations of oxidative stress marker malondialdehyde 
has been identified in mice blood levels post OP adminis-
tration [25]. In view of the association between mitochon-
dria dysfunction and cellular oxidative stress [17, 26], the 
ability of OPs to induce an increase in reactive oxidant 
species (ROS) generation may further support the potential 
mitochondrial toxicity of these group of compounds.
The increased oxidative stress and mitochondria dys-
function associated with OP treatment [17], may result 
from diminution in cellular  CoQ10 status as the result of 
exposure to these compounds.  CoQ10 functions as an elec-
tron carrier in the ETC as well as serving as a potent lipid 
soluble antioxidant [27]. Administration of  CoQ10 has pre-
viously been reported to alleviate mitochondrial oxida-
tive stress [28], as well as enhancing the activities of ETC 
complexes I-III and complex IV in rats treated with the 
OP, dichlorvos [24].  CoQ10 administration for 12 weeks 
prior to dichlorvos treatment was also found to improve 
cognitive performance, mitochondrial physiological fea-
tures and attenuate neuronal damage [29]. These findings 
suggest a potential role for  CoQ10 supplementation in the 
treatment of OP toxicity. Although, at present there is a 
paucity of information available on the therapeutic effi-
cacy of  CoQ10 in the treatment of the clinical symptoms 
associated with OP poisoning in human subjects. However, 
veterans suffering with Gulf War syndrome, a condition 
associated with OP poisoning, have been reported to show 
some clinical improvement following  CoQ10 treatment 
[30]. The factors responsible for biochemical and clini-
cal efficacy of  CoQ10 in the treatment of OP toxicity have 
yet to be elucidated. However, the possibility arises that 
the exogenous  CoQ10 may be replenishing an endogenous 
 CoQ10 deficiency induced by these synthetic compounds.
The present study evaluated the effect of OPs dichlo-
rovos, chloropyrifos and methyl-parathion on human 
neuronal cellular  CoQ10 status and mitochondrial func-
tion. In addition, the effect of  CoQ10 supplementation on 
mitochondrial function following OP exposure was also 
investigated.
Materials and Methods
Materials
All reagents were of analytical grade and obtained from 
Sigma-Aldrich Chemical (Poole, UK).
Neurochemical Research 
1 3
Cell Culture
SH-SY5Y human neuroblastoma cells (passage 17–24) 
were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 1% penicillin and strepto-
mycin and 10% foetal bovine serum (FBS). Cultures were 
maintained in an incubator with 5%  CO2 at 37 °C. At 
around 70–90% confluence, cells were harvested, wash-
ing twice with phosphate-buffered saline (PBS) followed 
by the addition of 3 ml of trypsin. Cells were seeded in 
plastic 96-well plates at a density of 20,000 cells/well or 
T75 flasks at 150,000 cells/ml prior to treatment with OPs. 
OP (dichlorvos, chloropyrifos and methyl-parathion) treat-
ment was carried out in 10% DMEM at concentrations 
of 10 µM, 50 µM and 100 µM and SH-SY5Y cells were 
treated with the OPs for 5 days. These concentrations were 
selected in the present study as these OP concentrations 
have been reported in the blood of individuals who are 
regularly exposed to OPs [31, 32], as well as in patients 
who have developed OP poisoning [33]. These concentra-
tions also parallel those used in previous studies [34–36]. 
Because the OPs were dissolved in ethanol, control cells 
were treated with the vehicle ethanol. Cells were further 
supplemented with  CoQ10 (5 µM) for 2 days with a further 
addition of the OPs (50 µM and 100 µM) according to the 
methods by Duberley et al. [37].
Cell Viability Assay
SH-SY5Y human neuroblastoma cell viability was obtained 
using the tetrazolium dye MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) assay. This col-
orimetric assay is based on the ability of the mitochon-
drial enzyme NADPH-dependant cellular oxidoreductase 
enzymes to reduce MTT to its purple coloured insoluble 
formazan. Trypan blue dye solution was added to the cells 
and dye excluding cells were counted using a haemocytom-
eter. Cells were plated and treated with OPs as previously 
described. MTT solution (20 µl) was added to each well of 
the 96 well plate post a 5 day incubation with the OPs. After 
a 3–4 h incubation with MTT at 37 °C, the formazan product 
was solubilized using 100 µl of DMSO and the absorbance 
of each well was read at 570 nm on a CLARIOstar® Plus.
ETC Enzyme Activities
The activities of the ETC complex II/III (succinate: 
cytochrome C reductase) and citrate synthase were determined 
spectrophotometrically at wavelengths of 412 nm and 550 nm 
respectively, according to methods described by Duberley 
et al. [38]. Complex II/III activities were expressed as a ratio 
to citrate synthase activity to account for mitochondrial enrich-
ment [39].
Total Protein Determination
Cellular protein concentration was determined by the method 
of Lowry et al. [40]. Protein standards were prepared by dilut-
ing BSA (0.2 mg/ml) in  H2O (0, 25, 50, 75, 100, 200 µg/
ml). Samples were diluted 1/100 in  H2O in Eppendorf tubes. 
100 µl of reagent A and 800 µl of reagent B were added to 
the Eppendorf tubes and standards. Absorbance was measured 
spectrophotometrically at 750 nm. Protein concentrations can 
be determined using relative absorbance of protein standards 
expressed as (mg/ml).
Lactate Measurement
Following a 5-day incubation with the OPs, 1 ml of culture 
media from control and OP treated cells was transferred to an 
Eppendorf tube and frozen at − 80 °C. Samples were thawed 
and immediately transferred to hospital grade grey topped 
Fluoride (K EDTA) tubes. The samples were analysed on the 
Roche Cobas c analyser using Roche 2nd generation LACT2 
colorimetric lactate assay. This assay utilises lactate oxidase 
to oxidise lactate to pyruvate with the generation of hydrogen 
peroxide. The hydrogen peroxide formed then reacts under 
a reaction catalysed by a peroxidase with phenol and 4-ami-
nophenazone to form a red-violet quinoneimine dye which 
absorbs at 500 nm. The resulting increase in absorption is 
proportional to the amount of lactate present in the sample.
Quantification of  CoQ10 Status
The  CoQ10 status of SH-SY5Y cells was determined using 
high pressure liquid chromatography with UV detection at 
275 nm according to the method of Duncan et al. [41]. The 
results were expressed pmol/mg of protein.
Statistical Analysis
All results are expressed as a mean ± standard deviation. One-
way ANOVA with Tukey’s multiple comparison post hoc test 
was used for comparison of groups > 2 using statistical soft-
ware GraphPad Prism. P < 0.05 was considered significant.
Results
Organophosphates Induced a Significant Reduction 
in Cell Viability
The MTT cytotoxicity assay was used to assess cellular 
metabolic activity post treatment with OPs. The percentage 
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(%) of viable cells following a 5 day incubation with a con-
centration of 10 µM of the OPs showed very little effect on 
cell viability (data not shown). However, at 50 µM MTT 
conversion was reduced significantly by 20% (P < 0.05) for 
parathion treated cells compared to control levels, which 
directly corresponds to a significant reduction in cell viabil-
ity (Fig. 1). Following a 5 day incubation with OPs (100 µM) 
dichlorvos, parathion and CPF there was an 80%, 55% and 
25% (P < 0.0001) significant reduction in cell viability 
respectively compared to control levels (Fig. 1).
Organophosphate Treatment had no Effect 
on Lactate Concentration
Incubation of SH-SY5Y cells with OPs dichlorvos, para-
thion and CPF (100 µM) resulted in no significant differ-
ence in lactate medium concentrations (mmol/l) compared 
to control levels (Fig. 2).
Organophosphates Induced Neuronal Coenzyme  Q10 
Deficiency
The  CoQ10 status of SH-SY5Y cells decreased following a 
5 day incubation with the OPs. Cellular  CoQ10 status sig-
nificantly decreased 72% (P < 0.0001), 62% (P < 0.0005) 
and 43% (P < 0.005) post treatment with dichlorvos, para-
thion and CPF (50 µM) respectively compared to control 
levels (Fig. 3). Cellular  CoQ10 status significantly decreased 
(P < 0.0001) by 52%, 64% and 40% post treatment with 
dichlorvos, parathion and CPF (100 µM) respectively com-
pared to control levels (Fig. 3).
CoQ10 Supplementation Demonstrated Protective 
Properties Against OP‑Induced Cellular Death
MTT cytotoxicity assay was used to measure cell viability 
(%) following 5 day incubations with OPs dichlorvos, para-
thion and CPF (100 µM), and then a further 2 day incubation 
with  CoQ10 (5 µM). Post treatment with  CoQ10 parathion 
and CPF treated cells resulted in a significant increase in cell 
viability, increasing 30% (P < 0.0005) and 18% (P < 0.0001) 
respectively compared to non-CoQ10 supplemented cells 
(Fig. 4).
Fig. 1  Cell viability (%) of SH-SY5Y cells following a 5 day incuba-
tion with OPs dichlorvos, parathion and CPF for concentrations of a 
50 µM (n = 3) b 100 µM (n = 3). Error bars represent standard devia-
tion; statistical analysis was carried out using one-way ANOVA with 
Tukey’s multiple comparison post hoc test; levels of significance: 
*p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001 compared to 
control levels
Fig. 2  Effect of 5  day treatments of OPs dichlorvos, parathion and 
CPF (100  µM) on SH-SY5Y cellular medium lactate concentration 
(mmol/L) (n = 3). Error bars represent standard deviation; statisti-
cal analysis was carried out using one-way ANOVA with Tukey’s 
multiple comparison post hoc test; levels of significance: *p < 0.05, 
**p < 0.005, ***p < 0.0005, ****p < 0.0001 compared to control lev-
els
Fig. 3  Effect of 5  day treatments of OPs dichlorvos, parathion and 
CPF on  CoQ10 content (pmol/mg) in SH-SY5Y cells. a 50 µM con-
centration of OPs (n = 3), b 100  µM concentration of OPs (n = 3). 
Error bars represent standard deviation; statistical analysis was 
carried out using one-way ANOVA with Tukey’s multiple com-
parison post hoc test; levels of significance: *p < 0.05, **p < 0.005, 
***p < 0.0005, ****p < 0.0001 compared to control levels
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CoQ10 Supplementation Improved OP‑Induced 
Alterations on CS Activity
Incubation of SH-SY5Y cells with OPs dichlorvos, para-
thion and CPF at 50 µM and 100 µM resulted in altera-
tions in citrate synthase (CS) (mitochondrial matrix marker 
enzyme) activity. At 50 µM concentrations, dichlorvos and 
CPF showed a significant reduction in CS activity, decreas-
ing 38% (P < 0.0001) and 35% (P < 0.0005) respectively 
compared to control levels (Fig. 5). At 100 µM concentra-
tions, dichlorvos and CPF showed a significant reduction 
(P < 0.0001) in CS activity, reducing 86% and 42% respec-
tively compared to control levels. However, parathion 
showed a significant increase (P < 0.0001) in CS activity, 
increasing 39% compared to control levels (Fig. 5).
Post supplementation with  CoQ10, CS activity signifi-
cantly increased by 47% (P < 0.0001) in dichlorvos (50 µM) 
treated cells compared to non-CoQ10 supplemented cells 
thus showing no significant difference from controls post 
treatment with  CoQ10. Post supplementation with  CoQ10, 
CS activity significantly increased (P < 0.05) by 20% in 
CPF (100 µM) treated cells compared to non-CoQ10 sup-
plemented cells (Fig. 5).
CoQ10 Supplementation Improved OP‑Induced 
Alterations in Complex II+III Activity
Incubation of SH-SY5Y cells with OPs dichlorvos, para-
thion and CPF at 50 µM and 100 µM resulted in altera-
tions in complex II+III activity. At 50 µM OP concentra-
tions, dichlorvos and CPF showed a significant reduction 
(P < 0.0001) in complex II+III activity, reducing 54% and 
57% respectively compared to control levels. Treatment with 
100 µM of dichlorvos showed no complex II+III activity. 
Parathion and CPF (100 µM) treated cells showed a sig-
nificant reduction (P < 0.0001) in complex II+III activity, 
reducing 66% and 67% respectively compared to control 
levels (Fig. 6).
Post supplementation with  CoQ10, complex II+III activity 
significantly increased (P < 0.005), increasing 32% and 28% in 
dichlorvos and CPF (50 µM) treated cells compared to non-
CoQ10 supplemented cells. Post supplementation with  CoQ10, 
Fig. 4  Effect of a 2  day supplementation with  CoQ10 following a 
5 day incubation with OPs dichlorvos, parathion and CPF (100 µM) 
in SH-SY5Y cells on cell viability (%). Error bars represent standard 
deviation; statistical analysis was carried out using one-way ANOVA 
with Tukey’s multiple comparison post hoc test; levels of signifi-
cance: *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001
Fig. 5  Effect of a 5  day incubation with OPs dichlorvos, parathion 
and CPF on citrate synthase activity in SH-SY5Y cells, followed by 
a further 2 day supplementation with  CoQ10 (5 µM) compared to con-
trols. a Citrate synthase activity post treatment with 50 µM of OPs, 
with and without a further 2 day supplementation with  CoQ10 (5 µM) 
(n = 3), b citrate synthase activity post treatment with 100 µM of OPs, 
with and without a further 2 day supplementation with  CoQ10 (5 µM) 
(n = 3). Error bars represent standard deviation; statistical analysis 
was carried out using one-way ANOVA with Tukey’s multiple com-
parison post hoc test; levels of significance: *p < 0.05, **p < 0.005, 
***p < 0.0005, ****p < 0.0001
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complex II+III activity significantly increased, increasing 33% 
(P < 0.0005), 25% (P < 0.005) and 35% (P < 0.0001) in dichlo-
rvos, parathion and CPF (100 µM) treated cells compared to 
non-CoQ10 supplemented cells (Fig. 6).
Discussion
The results of the present study have provided evidence 
of OP induced neuronal cell  CoQ10 deficiency which was 
associated with an impairment of ETC complex II+III 
activity. As far as the authors are aware, this is the first 
study to report an association between OP exposure and 
a deficit in cellular  CoQ10 status and this may offer an 
explanation for the ability of  CoQ10 supplementation to 
ameliorate some of the neurological symptoms associated 
with OP poisoning [42]. Furthermore, cerebral ataxia has 
been associated with OP poisoning which is one of the 
main clinical presentations of  CoQ10 deficiency [20].
A deficit in cellular  CoQ10 status was detected follow-
ing treatment with OPs dichlorvos, parathion and CPF (50 
and 100 µM) indicating the ability of OPs to induce neu-
ronal  CoQ10 deficiency with dichlorvos, inducing the most 
pronounced deficit in the status of this isoprenoid. The 
cause of the cellular  CoQ10 deficiency associated with OP 
exposure has yet to be elucidated, and may be due to the 
ability of these synthetic compounds to directly inhibit the 
 CoQ10 biosynthetic pathway or as the result of some other 
secondary mechanism. OPs associated with increased ROS 
generation may result in an increase in oxidative catabo-
lism as well as a possible inhibition of enzymes in the 
 CoQ10 biosynthetic pathway [17].
In view of the dependence of ETC complex II+III activ-
ity upon endogenous  CoQ10 status [43], we also assessed 
the effect of OP treatment on complex II+III activity. 
Interestingly, the decrease in cellular  CoQ10 status was 
found to accompany a significant loss in complex II+III 
activity, supporting the requirement for  CoQ10 for optimal 
complex II+III activity. This therefore indicates the poten-
tial for a deficit in  CoQ10 status to impair ETC activity. 
The activity of complex II+III was expressed as a ratio to 
CS to account for mitochondria enrichment. Therefore, we 
can assume that the reduction observed to complex II+III 
activity reflects impairment to oxidative phosphorylation 
rather than a loss in mitochondrial number [39]. ETC 
inhibition generates free radicals, leading to increased 
oxidative stress [44]. Since the ETC is highly susceptible 
to oxidative damage and ROS can directly damage mito-
chondrial enzymes [45], the possibility arises that the loss 
in complex II+III activity may also have resulted from 
OP-induced ROS generation [17, 25].
Importantly, the 65% reduction in complex II+III activity 
observed in chloropyrifos and parathion (100 µM) treated 
cells may not be sufficient to impair oxidative phospho-
rylation, as it has been previously reported that complex 
III activity has to be inhibited by 70–80% before oxidative 
phosphorylation is compromised [46]. In support of this, the 
assessed lactate medium levels post treatment with the OPs 
(100 µM) wasn’t found to be elevated compared to control 
levels, suggesting an upregulation of glycolytic metabolism 
was not required to compensate for impairment of oxida-
tive phosphorylation [47]. Alternatively, this may be due to 
a significant reduction in cell viability due to OP-induced 
toxicity.
Fig. 6  Effect of a 5  day incubation with OPs dichlorvos, parathion 
and CPF on complex II + III activity in SH-SY5Y cells, followed by 
a further 2 day supplementation with  CoQ10 (5 µM) compared to con-
trols. a Complex II + III activity post incubation with 50 µM of OPs, 
with and without a further 2 day supplementation with  CoQ10 (5 µM) 
(n = 3), b Complex II + III activity post incubation with 100  µM of 
OPs, with and without a further 2 day supplementation with  CoQ10 
(5  µM) (n = 3). Error bars represent standard deviation; statisti-
cal analysis was carried out using one-way ANOVA with Tukey’s 
multiple comparison post hoc test; levels of significance: *p < 0.05, 
**p < 0.005, ***p < 0.0005, ****p < 0.0001
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The significant increase in CS activity following treat-
ment of the neuronal cells with parathion (100 µM) would 
indicate that exposure to this synthetic compound induced an 
increase in mitochondrial biogenesis in the SH-SY5Y cells, 
which has been reported to occur as an adaptive response 
to impaired oxidative phosphorylation [48]. In contrast to 
the increase in CS activity, the level of neuronal  CoQ10 
was found to decrease following treatment with parathion 
and since approximately 45% of cellular  CoQ10 is found 
within the mitochondria [49], this would suggest that the 
diminution in cellular  CoQ10 status does not reflect the loss 
of mitochondrial enrichment. Contrary to parathion, CPF 
and dichlorvos induced a loss of neuronal cell CS activity 
which may reflect a loss of mitochondrial enrichment. A 
decrease in CS activity has previously been associated with 
a decrease in cellular ATP production, an increase in ROS 
production and accelerated cell death [50]. This may explain 
to some degree the evidence of cellular toxicity and loss of 
cell viability indicated by the MTT assay following exposure 
to OPs at concentrations of 50 µM and 100 µM. However, no 
evidence of toxicity was apparent when OPs were used at a 
concentration of 10 µM (data not shown).
There is a paucity of information available on the ability 
of  CoQ10 to ameliorate some of the adverse clinical effects 
associated with OP toxicity. However, a study by Bayir et al. 
[51] reported the ability of  CoQ10 to attenuate OP induced 
cardiac toxicity. Furthermore, a recent study by Belousova 
et al. [42] demonstrated that  CoQ10 improves neurological 
function in transient focal brain ischemia in rats [42]. Simi-
larly, the present study showed that  CoQ10 supplementation 
(5 µM) was able to restore parathion and CPF (100 µM) 
treated cell viability to control levels. OPs may induce toxic-
ity to cells by their ability to upregulate ROS production and 
downregulate antioxidant enzymes [52, 53]. Thus,  CoQ10 
may play roles in ameliorating OP induced toxicity by act-
ing as a free radical scavenger to mitigate DNA damage and 
lipid peroxidation from OP-induced oxidative stress, as well 
as elevating activities of antioxidant enzymes including OP 
detoxifying enzyme, paraxonase [29, 54].
CoQ10 supplementation was able to restore CS activity 
to control levels following treatment with the OPs dichlor-
vos and CPF (50 µM), but not in cells treated with 100 µM 
of OPs. Although the precise mechanism by which exog-
enous  CoQ10 induces this effect is uncertain, in its ability 
to act as an antioxidant  CoQ10 may protect the cell against 
OP induced oxidative stress and therefore prevent an 
impairment of oxidative phosphorylation or increased loss 
of mitochondrial enrichment [55]. However, further work 
will be required to evaluate the effect of CoQ10 supple-
mentation on OP-induced cellular oxidative stress. Alter-
natively,  CoQ10 may activate mitochondria biogenesis as 
indicated by the study of Jing et al. [56] which reported an 
increase in the ratio of COX-1 mitochondrial DNA to that 
of SDH-A nuclear DNA following treatment of cells with 
 CoQ10. This would therefore explain the restoration of CS 
activity (marker for mitochondrial enrichment) following 
treatment with  CoQ10 in cells exposed to OPs, dichlorvos 
and CPF (50 µM).
In addition,  CoQ10 treatment was found to increase 
ETC complex II+III activity, however the activity of this 
enzyme only reached control levels in cells treated with 
50 µM of dichlorovos. Treatment with 100 µM of this OP 
resulted in an apparent complete inhibition of complex 
II+III activity, possibly reflecting the significant loss of 
cell viability indicated by the MTT assay. Subsequent 
 CoQ10 supplementation was found to increase complex 
II+III activity to 34% of control levels in neuronal cells 
treated with 100 µM dichlorovos. The failure of  CoQ10 
supplementation to fully restore neuronal cell ETC com-
plex II+III activity to control levels following exposure 
to OPs (CPF, parathion and dichlorovos at 100 µM) may 
indicate that the loss of enzyme activity was not solely the 
result of a diminution in cellular  CoQ10 status and possibly 
the result of some other inhibitory mechanism. However, 
some studies have suggested that only 11% of an exog-
enous quinone is able to reach the mitochondrion [57] and 
therefore the failure of  CoQ10 supplementation to restore 
ETC complex II+III activity may be due to the dosage of 
 CoQ10 used in the study which was 5 µM. In agreement 
with this, a study by Duberley et al. [37] reported that a 
dosage of  CoQ10 above 10 µM may be required to fully 
restore ETC enzyme activity following a diminution of 
 CoQ10 status. complex II+III was not fully recovered post 
treatment with OPs (100 µM). However, in view of the 
MTT results, perbutation of complex II+III may not be 
sufficient to impair oxidative phosphorylation.
In conclusion, this study for the first time has indicated 
the possibility that OP exposure may result in a loss of cel-
lular  CoQ10 status which therefore may be a contributory 
factor to some of the clinical adverse side effects associ-
ated with OP exposure. Supplementation with  CoQ10 was 
able to restore OP-induced CS activity and cell viability 
to control levels in some cases. However, future work to 
evaluate the effect of OPs on oxidative stress levels and 
the ability for  CoQ10 to ameliorate OP-induced oxidative 
stress is required to fully identify the molecular mecha-
nism by which  CoQ10 improves mitochondria functioning 
in the present study.  CoQ10 supplementation was unable 
to fully restore ETC complex II+III activity to control 
levels in this study. This may reflect the dosage of the qui-
none used and higher doses (> 10 µM) may be required to 
elicit biochemical efficacy. Thus, targeted strategies aimed 
at restoring cellular  CoQ10 status following OP exposure 
should be considered, although further studies are first 
required to assess evidence of cellular  CoQ10 deficiency 
in patients following OP exposure.
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